Introducing Raymond T. Chung, M.D., Our 2021 AASLD President
Jules L. Dienstag – 23 March 2021
Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches
Cyril Dourthe, Céline Julien, Sylvaine Di Tommaso, Jean‐William Dupuy, Nathalie Dugot‐Senant, Alexandre Brochard, Brigitte Le Bail, Jean‐Frédéric Blanc, Laurence Chiche, Charles Balabaud, Paulette Bioulac‐Sage, Frédéric Saltel, Anne‐Aurélie Raymond – 22 March 2021
A Beautiful Day in the Neighborhood: Application of Single‐Cell Transcriptomics to Unravel Liver Cell Heterogeneity in Diseased Human Livers
Tianyi Chen, Anna Mae Diehl – 22 March 2021
Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone‐Dependent Release of Circulating Tumor DNA
Ismail Labgaa, Johann Felden, Amanda J. Craig, Sebastiao N. Martins‐Filho, Carlos Villacorta‐Martin, Nicolas Demartines, Olivier Dormond, Delia D’Avola, Augusto Villanueva – 22 March 2021 – Liquid biopsy, the molecular analysis of tumor components released into the bloodstream, has emerged as a noninvasive and resourceful means to access genomic information from cancers. Most data derived from translational studies showcase its numerous potential clinical applications.
REPLY:
Xuefeng Luo, Xiaoze Wang, Li Yang – 21 March 2021
Current Quandaries in the Management of Congenital Portosystemic Shunts
Valérie McLin, Maurice Beghetti, Lorenzo D’Antiga, Stéphanie Franchi‐Abella, the International Registry of Congenital Porto‐Systemic Shunts (IRCPSS) – 21 March 2021
Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study
Xinrong Zhang, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Lilian Yan Liang, Vicki Wing‐Ki Hui, Guan‐Lin Li, Henry Lik‐Yuen Chan, Grace Lai‐Hung Wong – 20 March 2021 – The benefit of colonoscopy and/or polypectomy for colorectal cancer (CRC) prevention in patients with nonalcoholic fatty liver disease (NAFLD) remains unclear. We aimed to estimate the incidence rate of CRC in patients with NAFLD who had and had not undergone colonoscopy.
Responsible Inclusion of Pregnant Individuals in Eradicating HCV
Ravi Jhaveri, Lynn M. Yee, Swati Antala, Margaret Murphy, William A. Grobman, Seema K. Shah – 19 March 2021 – HCV infections have increased in recent years due to injection drug use and the opioid epidemic. Simultaneously, HCV cure has become a reality, with the advent of direct‐acting antivirals (DAAs) and expansion of treatment programs. As a result, HCV screening recommendations now include all adults, including pregnant individuals; and many countries have endorsed widespread DAA access as a strategy to achieve HCV eradication.
Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease
Joseph W. Beals, Gordon I. Smith, Mahalakshmi Shankaran, Anja Fuchs, George G. Schweitzer, Jun Yoshino, Tyler Field, Marcy Matthews, Edna Nyangau, Darya Morozov, Bettina Mittendorfer, Marc K. Hellerstein, Samuel Klein – 19 March 2021
Responsible Inclusion of Pregnant Individuals in Eradicating HCV
Ravi Jhaveri, Lynn M. Yee, Swati Antala, Margaret Murphy, William A. Grobman, Seema K. Shah – 19 March 2021 – HCV infections have increased in recent years due to injection drug use and the opioid epidemic. Simultaneously, HCV cure has become a reality, with the advent of direct‐acting antivirals (DAAs) and expansion of treatment programs. As a result, HCV screening recommendations now include all adults, including pregnant individuals; and many countries have endorsed widespread DAA access as a strategy to achieve HCV eradication.